CMTM5 and breast carcinoma: The analyses involving MEXPRESS also indicated that the CMTM5 mRNA expression level was significantly lower in breast cancer tissues than in normal tissues and correlated with ER (P = 5.76e−5), PR (P = 3.84e−6), and menopause status (r = −0.0954) (Figure 9D).